• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童自身免疫性甲状腺功能减退与亢进交替症

Autoimmune alternating hypo- and hyperthyroidism in children.

作者信息

Mathew Revi P, Moore Daniel J

机构信息

Monore Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN 37232-9170, USA.

出版信息

Clin Pediatr (Phila). 2011 Nov;50(11):1040-4. doi: 10.1177/0009922811412583. Epub 2011 Jun 23.

DOI:10.1177/0009922811412583
PMID:21700620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3556509/
Abstract

Two children presented with autoimmune alternating hypo- and hyperthyroidism related to the presence of blocking and stimulating thyroid antibodies. It was difficult to control their thyroid function adequately with an appropriate single drug regimen, and both children underwent total thyroidectomy with subsequent stable management with levothyroxine replacement therapy postsurgically. Although this phenomenon is well described in adults, this report is the first of such occurrence in children. The possible mechanism for the variation in the type of clinical presentation and options for management are discussed.

摘要

两名儿童因存在甲状腺阻断抗体和刺激抗体而出现自身免疫性交替性甲状腺功能减退和亢进。采用适当的单一药物治疗方案很难充分控制他们的甲状腺功能,两名儿童均接受了甲状腺全切除术,术后通过左甲状腺素替代疗法进行稳定管理。虽然这种现象在成人中已有充分描述,但本报告是儿童中首例此类病例。本文讨论了临床表现类型变化的可能机制及治疗选择。

相似文献

1
Autoimmune alternating hypo- and hyperthyroidism in children.儿童自身免疫性甲状腺功能减退与亢进交替症
Clin Pediatr (Phila). 2011 Nov;50(11):1040-4. doi: 10.1177/0009922811412583. Epub 2011 Jun 23.
2
Laboratory tests for evaluating thyroid therapy.评估甲状腺治疗的实验室检查。
Am Fam Physician. 1982 Sep;26(3):183-8.
3
Graves' Disease: Can It Be Cured?格雷夫斯病:可以治愈吗?
Endocrinol Metab (Seoul). 2019 Mar;34(1):29-38. doi: 10.3803/EnM.2019.34.1.29.
4
Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism.一名患者在经历从甲状腺功能减退到甲状腺功能亢进再回到甲状腺功能减退的三个周期转变过程中,刺激和阻断促甲状腺激素受体抗体的变化。
Clin Endocrinol (Oxf). 1992 Feb;36(2):211-4. doi: 10.1111/j.1365-2265.1992.tb00960.x.
5
[Principles of thyroid hormone treatment (author's transl)].[甲状腺激素治疗原则(作者译)]
MMW Munch Med Wochenschr. 1980 Jun 27;122(26):961-6.
6
Fifteen-year follow-up of thyroid function in lithium patients.锂盐治疗患者甲状腺功能的15年随访
J Endocrinol Invest. 2007 May;30(5):363-6. doi: 10.1007/BF03346311.
7
Thyroid medications during pregnancy.孕期甲状腺药物
Ther Drug Monit. 2006 Jun;28(3):431-41. doi: 10.1097/01.ftd.0000211834.41844.82.
8
Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.干扰素α治疗与甲状腺功能检查在丙型肝炎管理中的相互作用:一例报告
J Med Case Rep. 2016 Sep 15;10(1):253. doi: 10.1186/s13256-016-1028-y.
9
Hypothyroidism to hyperthyroidism: an immunological pendulum swing from two extreme poles - a case series.甲状腺功能减退至甲状腺功能亢进:从两个极端的免疫摆动——病例系列
BMJ Case Rep. 2019 Apr 5;12(4):e227445. doi: 10.1136/bcr-2018-227445.
10
Thyroid-stimulating antibody and thyrotropin-binding inhibitory immunoglobulin activity in hypothyroid patients who subsequently developed thyrotoxicosis.随后发生甲状腺毒症的甲状腺功能减退患者的促甲状腺素抗体和促甲状腺素结合抑制性免疫球蛋白活性
Acta Endocrinol (Copenh). 1990 Apr;122(4):499-504. doi: 10.1530/acta.0.1220499.

引用本文的文献

1
Oscillation between Hyperthyroidism and Hypothyroidism in an Adolescent Female with Graves' Disease.一名患有格雷夫斯病的青春期女性甲状腺功能亢进与甲状腺功能减退的交替发作
J ASEAN Fed Endocr Soc. 2025 May;40(1):117-120. doi: 10.15605/jafes.040.01.07. Epub 2025 Apr 25.
2
ALTERNATING HYPOTHYROIDISM AND HYPERTHYROIDISM IN AN ADOLESCENT BOY - DO WE ALWAYS UNDERSTAND WHAT DRIVES THE SWITCH?青少年的交替性甲状腺功能减退症和甲状腺功能亢进症 - 我们是否总能理解促使病情转变的原因?
Acta Clin Croat. 2023 Nov;62(3):546-550. doi: 10.20471/acc.2023.62.03.17.
3
Phenotypic Expression of Autoimmunity in Children With Autoimmune Thyroid Disorders.自身免疫性甲状腺疾病患儿自身免疫的表型表达
Front Endocrinol (Lausanne). 2019 Jul 12;10:476. doi: 10.3389/fendo.2019.00476. eCollection 2019.
4
Alternating hyperthyroidism and hypothyroidism in Graves' disease.格雷夫斯病中的甲亢与甲减交替出现。
Clin Case Rep. 2018 Jul 9;6(9):1684-1688. doi: 10.1002/ccr3.1700. eCollection 2018 Sep.
5
Autoimmune alternating hyper- and hypo-thyroidism: a rare condition in pediatrics.自身免疫性甲状腺功能亢进与减退交替:儿科中的一种罕见病症。
Endocrinol Diabetes Metab Case Rep. 2016;2016:150131. doi: 10.1530/EDM-15-0131. Epub 2016 Feb 9.
6
Oscillating hypothyroidism and hyperthyroidism - a case-based review.甲状腺功能减退症与甲状腺功能亢进症的交替发作——基于病例的综述
J Community Hosp Intern Med Perspect. 2014 Nov 25;4(5):25734. doi: 10.3402/jchimp.v4.25734. eCollection 2014.

本文引用的文献

1
Thyroidectomy for selected patients with thyrotoxicosis.为部分甲状腺毒症患者实施甲状腺切除术。
Arch Otolaryngol Head Neck Surg. 2001 Jan;127(1):61-5. doi: 10.1001/archotol.127.1.61.
2
The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.未经治疗的甲状腺功能亢进型格雷夫斯病中促甲状腺激素受体阻断性抗体的患病率及临床意义。
Thyroid. 2000 Jul;10(7):579-86. doi: 10.1089/thy.2000.10.579.
3
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.甲状腺功能亢进症的治疗与格雷夫斯眼病病程之间的关系。
N Engl J Med. 1998 Jan 8;338(2):73-8. doi: 10.1056/NEJM199801083380201.
4
Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease.对一名桥本氏病患者的单克隆促甲状腺和促甲状腺素结合抑制性自身抗体的特征分析,该患者的子女患有宫内和新生儿甲状腺疾病。
J Clin Endocrinol Metab. 1997 Dec;82(12):3998-4009. doi: 10.1210/jcem.82.12.4433.
5
Changes in epitopes for thyroid-stimulating antibodies in Graves' disease sera during treatment of hyperthyroidism: therapeutic implications.格雷夫斯病血清中促甲状腺素抗体表位在甲状腺功能亢进治疗期间的变化:治疗意义
J Clin Endocrinol Metab. 1997 Jun;82(6):1953-9. doi: 10.1210/jcem.82.6.3999.
6
Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor.使用表达野生型或嵌合型人促甲状腺激素受体的CHO细胞通过各种检测方法分类的抗促甲状腺激素受体抗体亚型。
Thyroid. 1997 Feb;7(1):13-9. doi: 10.1089/thy.1997.7.13.
7
Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment.格雷夫斯病血清中促甲状腺素抗体的表位:异质性与抗甲状腺药物治疗反应差异之间的可能联系。
J Clin Endocrinol Metab. 1996 May;81(5):1758-67. doi: 10.1210/jcem.81.5.8626830.
8
Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.促甲状腺激素受体N端区域甲状腺刺激抗体特异性相互作用位点的鉴定。
Mol Endocrinol. 1993 Jan;7(1):114-30. doi: 10.1210/mend.7.1.8095322.
9
Characterization of monoclonal antibodies derived from lymphocytes from Graves' disease patients in a cytochemical bioassay for thyroid stimulators.在甲状腺刺激物的细胞化学生物测定中对来自格雷夫斯病患者淋巴细胞的单克隆抗体进行表征。
J Clin Endocrinol Metab. 1984 May;58(5):909-14. doi: 10.1210/jcem-58-5-909.
10
Monoclonal antibodies to the thyrotropin receptor: implications for receptor structure and the action of autoantibodies in Graves disease.促甲状腺激素受体单克隆抗体:对受体结构及格雷夫斯病中自身抗体作用的影响
Proc Natl Acad Sci U S A. 1981 May;78(5):3180-4. doi: 10.1073/pnas.78.5.3180.